# Sipuleucel-T With or Without Radiation Therapy in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer

> **NCT01807065** · PHASE2 · COMPLETED · sponsor: **City of Hope Medical Center** · enrollment: 51 (actual)

## Conditions studied

- Adenocarcinoma of the Prostate
- Bone Metastases
- Hormone-resistant Prostate Cancer
- Recurrent Prostate Cancer
- Soft Tissue Metastases
- Stage IV Prostate Cancer

## Interventions

- **BIOLOGICAL:** sipuleucel-T
- **RADIATION:** external beam radiation therapy
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT01807065
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06-07
- **Primary completion:** 2018-12-31
- **Final completion:** 2019-12-31
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2020-08-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01807065

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01807065, "Sipuleucel-T With or Without Radiation Therapy in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01807065. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*